Investment Q&A

Q: Hi Peter and Ryan,

What is your outlook on Nektar Therapeutic?

Would you be a buyer after it's experiment of cancer drug disappointment.

Thank you for your help as always.

Q: Now that a couple more quarters have passed since the last question you received on Roots, what are your thoughts on the company today?

Q: Most analysts seem to have a generally positive view of BCE, saying it is fine for income, but they don't expect much growth. Despite the yield, in 2018 the stock has declined from about $60 to about $55 - the same price as at the beginning of 2016 - which is negative 8% YTD. The decline more than eliminates the yield. Everyone seems to think that "interest sensitive" stocks like this one decline when interest rates rise (which might make some sense if the interest rate rise were more than the tiny amounts we are seeing). But my question is whether there is more at play here. Without exception, the BCE consumers I know absolutely hate the company and are planning to switch service providers as soon as possible. Is this the sign of trouble on the horizon for this "widows and orphans" stock ??

Q: Would you expect PBH to hold up as well as Loblaw in a downturn? I hold both as part of my non-cyclical portion of my portfolio but I view PBH's growth prospects as greater and am therefore considering selling Loblaw. I realize that Loblaw is significantly larger although your report shows PBH's shares did hold up well in the last recession. My main concern with PBH is that a significant portion of revenues/profits comes from specialty foods. Would you expect this sector to hold up well in a downturn as I don't know if PBH product mix has changed significantly since 2008? I have no intention of selling PBH - I am just wondering if I can find a better substitute for Loblaw.

Appreciate your insight.

Paul F.

Q: It's been a little bit since BRE has been in the question spotlight. The stock has been acting well and the div is juicy. Are you still lukewarm because of its size? Any other concerns? The Brookfield name has to be a positive, yes?

Thanks!

Q: I would like to bump up my energy holdings in RRSPs, looking at CNQ and VET.
I'm leaning towards VET because of higher yield and lower debt. Your comments would be appreciated and thanks for the great service guys!

Scott

Q: Looking to add to consumer staples exposure. I am looking for best-in-class in the sector. PBH has performed spectacularly, and ATD.B has a great long-term track record, but poor 12-month performance. Leaning somewhat towards PBH, but would like to hear your thoughts. Thanks so much!

Q: Have held CHE.UN and growing tired of its performance.
Can you suggest replacement for dividend equivalent and growth potential

Q: I hold these in my us tfsa and each are weighted to about 4% of my total portfolio except nvda which grew to a nice 7%. I have some cash to add and wondering which I should top off first?

Q: Hello, What are your thoughts on Adobe as a long term hold? If would rather own some thing else in the US which shows a lot of promise in the long run what would it be? Thanks.

Shyam

Q: any current thoughts about FCF. Seems to be weakening lately. Thanks

Q: Hello team,

What is the issue with LLG? Is this still a viable speculative investment or is it time to move on?

Thanks for making investing possible for us all!

Q: Could you update your view on SGYP
Thank you

Q: Hi,
All the forecasts I’ve read for 1 year target for photon put it around 2.2-2.25. At 2.3 today, do you see much upside left or is the best part of this ride over? I’ve done well with it, so thanks to 5i for making me aware of it. If I was to cash out, do you have any other names for high growth companies that you would recommend a switch to? please name your top 3-4 as I own many of the companies you regularly recommend.

Thanks

Q: I would like your thoughts about WEED and if it is worth buying again. FYI I originally had it at $2.80 and have made a lot of money on it, but am concerned that it has a 7 Billion market cap with small revenue and could be vastly overpriced at these levels. Is it a buy or sell. Thanks in advance.

Q: With regard to Jim's question about helium-related companies, there is also DME (Desert Mountain Energy, after a recent name change from African Queen Mines) on the Venture Exchange. It also definitely falls into the extremely small and risky category. Market cap $5 million. Who knew that you "mined" helium? It also has a tiny O&G presence in Oklahoma and some gold interests in BC.

Q: I have 5 stocks. I would like you to rank them for growth over the next twelve months. They are DOCU, OKTA, AMOT, FNKO and TTD. Thank you, Dennis

Q: Peter; It seems to me that the announcement this afternoon re the convertible dispute was obviously known by some traders which accounts for the drop and volume. Surely IROC and/or the OSC should be aware of this and take some sort of action? I guess this a question but more of how it can happen?
Rod

Q: DOL splits 1 to 3 as at close,June 14.If I buy tomorrow before close,do I get the split?Thanks for u usual great services & views

Q: Your thoughts on the court ruling in favour of AT&T's acquisition of Time Warner please. With the price drop today it yields 6% with a P/E of 7. Seems attractive. Can you offer any insight as to why the markets hold it so out of favour?